Literature DB >> 1831979

Characterization of immunoreactive human C-type natriuretic peptide in brain and heart.

N Minamino1, Y Makino, H Tateyama, K Kangawa, H Matsuo.   

Abstract

Amino acid sequence of human C-type natriuretic peptide (CNP) has recently been deduced to be identical to those of porcine and rat CNPs in the bioactive unit of C-terminal 22 residues (CNP-22) (1). Thus, tissue concentrations and molecular forms of immunoreactive (ir-) CNP in human brain and heart were determined or characterized using a radioimmunoassay established for porcine CNP. In human brain (hypothalamus and medullapons), ir-CNP was detected at a concentration of 1.04 pmol/g, being about 25 times or 70 times higher than ir-atrial (A-type) natriuretic peptide (ANP) or ir-brain (B-type) natriuretic peptide (BNP). CNP was present mainly as CNP-53, with CNP-22 as well as 13K CNP (presumed to be pro-CNP) as minor components. In heart, 1 approximately 5 pmol/g of ir-CNP was detected in both atrium and ventricle, but this ir-CNP was shown to be derived from crossreactivity of ANP. These results demonstrated that human CNP functions exclusively in the central nervous system in contrast to ANP and BNP which mainly function in the circulation system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831979     DOI: 10.1016/0006-291x(91)91404-z

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

Review 2.  The endocrinology of food intake.

Authors:  Denovan P Begg; Stephen C Woods
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

Review 3.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

Review 4.  Brain natriuretic peptide and optimal management of heart failure.

Authors:  Nan Li; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

5.  C-type natriuretic peptide modulates permeability of the blood-brain barrier.

Authors:  Manoj Bohara; Yuki Kambe; Tetsuya Nagayama; Hiroshi Tokimura; Kazunori Arita; Atsuro Miyata
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-08       Impact factor: 6.200

6.  Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.

Authors:  R B Crook; A T Chang
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

7.  Characterization of natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour cell line.

Authors:  A F Gilkes; P H Ogden; S B Guild; G Cramb
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

Review 8.  Cardioprotective actions of peptide hormones in myocardial ischemia.

Authors:  Dwaine S Burley; Shabaz A Hamid; Gary F Baxter
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 9.  Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.

Authors:  Ines Pagel-Langenickel; Jens Buttgereit; Michael Bader; Thomas H Langenickel
Journal:  J Mol Med (Berl)       Date:  2007-04-12       Impact factor: 4.599

10.  Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.